6.
Milloy M, Wood E, Small W, Tyndall M, Lai C, Montaner J
. Incarceration experiences in a cohort of active injection drug users. Drug Alcohol Rev. 2009; 27(6):693-9.
DOI: 10.1080/09595230801956157.
View
7.
Eshun-Wilson I, Rohwer A, Hendricks L, Oliver S, Garner P
. Being HIV positive and staying on antiretroviral therapy in Africa: A qualitative systematic review and theoretical model. PLoS One. 2019; 14(1):e0210408.
PMC: 6328200.
DOI: 10.1371/journal.pone.0210408.
View
8.
Collins A, Boyd J, Mayer S, Fowler A, Kennedy M, Bluthenthal R
. Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites. Int J Drug Policy. 2019; 73:199-207.
PMC: 7147938.
DOI: 10.1016/j.drugpo.2019.08.002.
View
9.
Shirley-Beavan S, Roig A, Burke-Shyne N, Daniels C, Csak R
. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain. Harm Reduct J. 2020; 17(1):78.
PMC: 7574529.
DOI: 10.1186/s12954-020-00429-5.
View
10.
Radojcic N
. Building a Dignified Identity: An Ethnographic Case Study of LGBT Catholics. J Homosex. 2016; 63(10):1297-313.
DOI: 10.1080/00918369.2016.1151698.
View
11.
Dingle G, Cruwys T, Frings D
. Social Identities as Pathways into and out of Addiction. Front Psychol. 2015; 6:1795.
PMC: 4663247.
DOI: 10.3389/fpsyg.2015.01795.
View
12.
Berends L
. Problematisation and centralised assessment in drug treatment sector reform. Int J Drug Policy. 2019; 80:102561.
DOI: 10.1016/j.drugpo.2019.09.009.
View
13.
Kotyuk E, Farkas J, Magi A, Eisinger A, Kiraly O, Vereczkei A
. The psychological and genetic factors of the addictive behaviors (PGA) study. Int J Methods Psychiatr Res. 2018; 28(1):e1748.
PMC: 6877275.
DOI: 10.1002/mpr.1748.
View
14.
Pitt R
. "Still looking for my Jonathan": gay Black men's management of religious and sexual identity conflicts. J Homosex. 2010; 57(1):39-53.
DOI: 10.1080/00918360903285566.
View
15.
Degenhardt L, Mathers B, Wirtz A, Wolfe D, Kamarulzaman A, Carrieri M
. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries. Int J Drug Policy. 2013; 25(1):53-60.
DOI: 10.1016/j.drugpo.2013.08.004.
View
16.
Barratt M, Seear K, Lancaster K
. A critical examination of the definition of 'psychoactive effect' in Australian drug legislation. Int J Drug Policy. 2016; 40:16-25.
DOI: 10.1016/j.drugpo.2016.10.002.
View
17.
Longabaugh R, Wirtz P, Zywiak W, OMalley S
. Network support as a prognostic indicator of drinking outcomes: the COMBINE Study. J Stud Alcohol Drugs. 2010; 71(6):837-46.
PMC: 2965482.
DOI: 10.15288/jsad.2010.71.837.
View
18.
Gardner E
. Addiction and brain reward and antireward pathways. Adv Psychosom Med. 2011; 30:22-60.
PMC: 4549070.
DOI: 10.1159/000324065.
View
19.
Seear K, Fraser S
. The addict as victim: producing the 'problem' of addiction in Australian victims of crime compensation laws. Int J Drug Policy. 2014; 25(5):826-35.
DOI: 10.1016/j.drugpo.2014.02.016.
View
20.
Melamede R
. Harm reduction--the cannabis paradox. Harm Reduct J. 2005; 2:17.
PMC: 1261530.
DOI: 10.1186/1477-7517-2-17.
View